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ABSTRACT 
ASSOCIATION BETWEEN SERUM FERRITIN AND BODY COMPOSITION IN 
YOUNG WOMEN 
SEPTEMBER 2009 
 
UJJWALA S DANDEKAR, B.S., SNDT UNIVERSITY, MUMBAI, INDIA 
 
P.G.DIPLOMA, PUNE UNIVERSITY, INDIA 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Alayne Ronnenberg 
 
 
 
Iron deficiency is the most common nutrient disorder, affecting nearly two 
billion people worldwide. Young, premenopausal women are among those at greatest 
risk for iron deficiency. Optimal iron status is critical for work performance, growth, 
and maternal and fetal health. The prevalence of obesity is a rapidly increasing in both 
industrialized and underdeveloped countries. Previous studies have indicated that excess 
adiposity is associated with depleted iron status in adults. Our study explored the dietary 
and lifestyle factors associated with measures of iron status in young women. We also 
assessed the potential relationship between iron status and adiposity. Data were obtained 
from the University of Massachusetts Vitamin D Status Study, a cross-section study of 
women aged 18- 30 years. Height and weight were obtained to calculate body mass 
index (BMI, kg/m2). Dual x-ray absorptiometry (DXA) was used to measure percent 
body fat (%BF). Serum ferritin (SF) and high-sensitivity C reactive protein (hs-CRP) 
were measured in fasting blood samples. Dietary intake was estimated using the Willett 
semi-quantitative food frequency questionnaire. While total iron intake did not predict 
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serum ferritin levels, major contributors of iron intake were cereals, vegetables, lentils 
and supplemental iron in the multivariable regression models, which were adjusted for 
energy intake.  Iron deficiency (SF <12 µg/L) was observed in 28% of the population, 
and high %BF (>32%) was found in 45.4% of the population. Although age and hs-CRP 
were positively associated with serum ferritin (p <0.01), no association was observed 
between serum ferritin and body fat percent (p>0.05). However, hs-CRP was 
significantly correlated to BMI and body fat percent (p <0.01).  Among the menstrual 
characteristics, number of bleeding days was inversely associated with serum ferritin. 
Mean serum ferritin was significantly lower in oral contraceptive users than in nonusers 
(24.8 (22.8) vs 28.3 (20.5); p<0.05). Our findings suggest that in this population of 
young, predominantly normal-weight women, adiposity is not a strong predictor of iron 
status. Additional studies are needed to define the relationship between iron status and 
adiposity in obese women.  
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CHAPTER 1 
LITERATURE REVIEW 
Introduction 
Iron deficiency is one of the most prevalent nutrient disorders. It affects 
approximately two billion people worldwide and is the most common cause of anemia 
(WHO 2002). Although the prevalence of iron deficiency is greater in developing 
nations, it remains a health issue in industrialized countries as well. Because iron plays a 
key role in maternal and fetal health, understanding the factors that contribute to iron 
deficiency is particularly important in women of reproductive age. According to 
NHANES 1999-2000 data, the prevalence of iron deficiency in the United States was 
16% and 12%, respectively, in non-pregnant females aged 16-19 and 20-49 years (CDC 
2000). Women of child-bearing age are susceptible to iron deficiency due to periodic 
menstrual blood loss, and, in pregnant women, the increased iron needs of the fetus. 
Maternal iron deficiency is associated with low infant birth weight and preterm delivery 
(Scholl and Hediger 1994; Ronnenberg and others, 2004). 
The prevalence of obesity in the United States sharply increased from less than 
10% in 1990 to 25% in 2007 (CDC 2007).  In population studies, increased adiposity 
has been found to be a risk factor for iron deficiency (Gillum 2001; Yanoff and others 
2007). However, very few studies have investigated this association in young pre-
menopausal women. Therefore, our study assessed the association and predictive value 
of body fat, dietary and lifestyle factors on serum ferritin, a biomarker of iron stores, in 
a population of 18- to 30-year-old women.  
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Functions of iron 
Iron is a vital element in all aerobic organisms, and it plays critical functions in 
the human body, largely attributable to its oxygen-carrying capacity. The amount of iron 
present in a healthy adult is two to four grams. Iron is a binding site for oxygen in heme-
containing proteins, such as hemoglobin in red blood cells and myoglobin in muscle. 
Heme consists of a ferrous (Fe2+) iron complex within protoporphyrin IX. (Baynes and 
Stipanuk 2000)  Porphyrin is a cyclic macromolecule that binds divalent and trivalent 
metals like iron to form complexes. Thus, hemoglobin and myoglobin perform the 
important function of oxygen transport in human body. (Baynes and Stipanuk 2000) 
Iron is a redox (reduction-oxidation reaction) active transition metal that exists 
mainly in two oxidative states—ferrous (Fe2+) and ferric (Fe3+). Iron actively 
participates in electron transfer chains by reducing ferric iron to ferrous iron and 
supplying proton (H+) ions to the cytochromes.  Heme, therefore, is an essential 
component of cytochrome proteins, which comprise the electron transport chain.  
In addition, iron is also an integral part of iron-sulfur (Fe-S) proteins, which are 
present in mitochondrial enzymes, thus playing an important role in mitochondrial 
single electron transport.  These Fe-S proteins, also known as Fe-S clusters, appear in 
different forms based on equal number of iron and sulfur ions, with the most common 
Fe-S clusters being 2Fe-2S and 4Fe-4S. (Baynes and Stipanuk 2000; Andrews 2000; 
Beard 2001) 
Iron homeostasis 
It is critical to maintain normal levels of iron in the body since iron in excess can 
cause toxicity by contributing to free radical production and oxidative stress. As 
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mentioned earlier, iron is a transition element that is redox active. When iron is in 
excess, it reacts with hydrogen peroxide (H2O2) to produce highly toxic free radicals, 
such as superoxide (O2-) and hydroxyl (OH). This reaction, known as the Fenton 
reaction, is characterized by reaction of ferrous (Fe2+) iron with hydrogen peroxide 
(H2O2), producing ferric (Fe3+) iron and a hydroxyl radical. This toxicity can cause cell 
injury, such as DNA damage, lipid peroxidation and oxidative damage to proteins. 
(Valko, Morris, Cronin 2005) 
Maintaining whole-body iron homeostasis is an important and dynamic process 
involving several mechanisms, including regulation of intestinal iron uptake, cellular 
availability, storage and transport through various proteins.  
 
Regulation of iron availability 
Iron availability is tightly regulated by an array of proteins, including transferrin 
(Tf) and ferritin, which are responsible for iron transport and storage, respectively.  
These proteins bind iron in the ferric (Fe3+) form, which is non-reactive. This helps 
inhibit the reaction of free iron with oxygen, which can lead to free radical formation 
and cell injury.  
Iron availability in the body is regulated through intestinal absorption, posttranslational 
regulatory mechanisms, recycling of iron in macrophages and cellular storage of iron.  
 Iron absorption is regulated by transport of iron through the small intestine, 
which depends on the rate of erythropoiesis and the reduction in body iron stores. 
Erythropoeisis takes place in bone marrow. The ferrous iron absorbed from the diet and 
transported by the plasma protein transferrin, as well as iron recycled by 
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reticuloendothelial macrophages, is taken up by the bone marrow erythroblasts.  Excess 
iron is stored in the form of ferritin. Iron is stored primarily in hepatocytes. 
Erythropoiesis continues to use this stored iron in case of reduced supply or loss of iron. 
(Andrews 2000) 
 
Intestinal absorption of non-heme iron 
Dietary non-heme iron is absorbed in the proximal duodenum of small intestine. 
A protein known as divalent metal transporter- 1 (DMT-1), present on the brush border 
membrane of the enterocyte, is responsible for the uptake of non-heme iron. The non-
heme iron is in the ferric (Fe3+) form, which is insoluble. It is reduced by an unidentified 
ferrireductase along with duodenal cytochrome b (Dcytb). The exact ferrireductase has 
not been identified yet, since Dcytb was not found to be entirely responsible for 
reducing ferric iron at the brush border membrane (Gunshin and others 2005).  The 
ferrous (Fe2+) iron is then transported by DMT-1 into the enterocyte. It is a proton (H+) 
coupled transport process, which takes place at a low pH (Gunshin and others 1997).  
Iron is exported from the enterocyte to the circulation by a protein named ferroportin 
(Fpn), situated at the basolateral membrane. Likewise, Fpn is also located at the 
macrophage membrane, where it exports recycled iron harvested from senescent RBCs 
(Hentze, Muckenthaler, Andrews 2004). The ferrous iron thus exported from the 
enterocyte is then oxidized by ferroxidase, called hephaestin, in the interstitial space to 
the ferric form again. Thus, ferric iron bound to transferrin enters the circulation or is 
stored as ferritin (Andrews 2008).  The diferric transferrin is utilized further for 
erythropoiesis and storage.  Depletion of iron stores in the form of ferritin triggers 
  5 
 
upregulation of DMT1, which results in enhanced intestinal uptake of iron (Gunshin and 
others 1997). 
 
 
 
 
 
 
 
Figure 1: Intestinal non-heme iron absorption    
(Source: Gunshin H) 
 
The transferrin cycle 
Transferrin is a plasma protein secreted primarily by hepatocytes. Tf is an iron transport 
protein whose key role is the formation of RBCs, called erythropoiesis. 
 
Figure 2: The transferrin cycle: Receptor mediated endocytosis 
(Source: Gunshin H) 
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Tf binds iron and transports it to the cells for further use. It has two binding sites for 
ferric (Fe3+) iron. For cellular uptake, iron is internalized with transferrin (Tf) receptors 
(TfR) in the diferric form. The process through which iron is internalized into the 
endosome of red blood cells is known as endocytosis.  The Tf-Fe3+ complex binds to the 
transferrin receptor (TfR1) present on the cell surface. This complex is then internalized 
through clathrin-coated pits, which are vesicles for endocytosis. The bound iron is then 
released within the endosomes due to their acidification by a proton pump. Ferric iron 
released from the Tf-TfR1 complex is reduced to ferrous iron. DMT-1 then transports 
Fe2+ from the endosomal membrane into the cytoplasm to be further used by 
mitochondria or stored in the form of ferritin. Iron is stored mainly in 
reticuloendothelial macrophages and hepatocytes. These iron stores are then utilized 
during reduced supply or deficiency (Hentze, Muckenthaler, Andrews 2004). 
 
Post transcriptional regulation of iron 
Cellular iron balance is maintained at a post-transcriptional level by iron 
regulatory proteins that bind with RNAs. Iron regulatory proteins (IRP) contain a iron-
sulfur complex and are an isoform of cytosolic aconitase. When cellular iron stores are 
replete, IRP is iron saturated and actively binds RNA. In case of iron deficiency, 
however, the iron-sulfur cluster in IRP becomes unstable and, consequently, binds to 
iron responsive elements (IRE). IREs are stem-loop structures that are present in 5’ or 3’ 
untranslated regions (UTR) of mRNAs.  
Therefore, when the cellular iron pool is depleted, IRP binds to the 5’ UTR of 
ferritin mRNA, thus preventing the biosynthesis of ferritin. As a result, iron is not stored 
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during iron deficiency. Simultaneously, when IRP binds to the 3’ UTR of the transferrin 
receptor mRNA, it results in the stabilization of mRNA. Thus, mRNA is intact for a 
longer period of time to trigger synthesis of TfR, thus elevate the uptake of iron by cells.  
Both ferritin and TfR levels in the serum are important indicators of iron status: low 
ferritin and high TfR concentrations are biomarkers of iron deficiency  (Baynes and 
Stipanuk 2000).  
Recycling of iron 
Recycling of iron takes place in macrophages of the reticuloendothelial system, 
which take up old RBCs by phagocytosis. Iron from hemoglobin is then recycled and 
transported across the macrophage membrane by Fpn to the circulation and to the liver 
for storage. (Andrews 2000)  
 
Figure 3: Recycling of iron in macrophages 
(Source: Gunshin H) 
 
Proteins in iron metabolism 
Ferritin 
Ferritin is an iron storage protein characterized by 24 subunits. These subunits 
are comprised of heavy (H) and light (L) chains, which form a hollow apoferritin shell 
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and hold nearly 4500 atoms of iron. Apoferritin binds iron in its ferrous (Fe2+) form and 
then oxidizes it to ferric (Fe3+) iron. In this form iron is non-reactive and thus, non-toxic 
to the cells. The H subunit of ferritin has ferroxidase activity, which is an essential 
characteristic of this iron storage protein. The heavy subunit is found mainly in heart 
tissue, and the light subunit is found in liver cells. (Macara, Hoy, Harrison 1973) 
Once iron is absorbed in the duodenum, it is transported across the enterocyte 
and is either transported to cells in the transferrin-bound form, or the surplus iron is 
stored in the form of ferritin. When iron is required for erythropoiesis, it is released 
from ferritin. Thus, ferritin levels can reflect an early stage of iron deficiency in a 
normal healthy adult and are considered a sensitive biomarker of iron deficiency. 
However, chronic inflammatory conditions can alter serum ferritin levels, resulting in a 
false estimation of iron stores. This can be explained by alterations in ferritin due to the 
inflammatory response. 
Ferritin is a positive acute-phase protein, which means that its levels rise in 
response to inflammation. Stimulation of interleukins such as IL-1 and IL-6 gives rise to 
increased transcription of ferritin. Thus, chronic inflammatory conditions cause 
increased serum ferritin levels. Inflammatory cytokines can also cause downregulation 
of Fpn, which results in sequestration of iron in the macrophages (Weiss and 
Goodnough 2005).  Therefore, in inflammatory conditions or chronic disease, serum 
ferritin can be elevated and might not serve as an appropriate measure of iron status.   
Hephaestin 
Hephaestin is a ferroxidase located at the basolateral membrane of enterocytes. It 
facilitates the conversion of ferrous iron (Fe2+) to ferric iron (Fe3+), thus being 
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responsible for iron export from the intestinal cell to the circulation. It is a copper 
dependent protein and is homologous to ceruloplasmin. The Tf-bound ferric iron then 
enters the circulation. (Andrews 2000) 
 
Figure 4: Iron storage and transport proteins 
 (Source: Andrews NC 2000) 
 
Hepcidin 
Hepcidin is a peptide hormone which is synthesized by the hepatocytes. It is 
homologous to anti-microbial defensin peptide present in the human immune system, 
which explains its potential role in inflammation and defense system (Park and others 
2001).  Hepcidin appears to be instrumental in iron metabolism, regulating the export of 
absorbed intestinal iron. This mechanism can be explained by the binding of hepcidin 
with ferroportin (Fpn) (Nemeth and others 2004c; Nemeth and others 2004b).  As 
mentioned earlier, Fpn is an iron-transport protein primarily located at the basolateral 
membrane of intestinal cells as well as macrophages. Hepcidin binds with Fpn at the 
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membrane, and this complex is then internalized and degraded by lysosomal enzymes. 
As a result, Fpn degradation inhibits iron export from the intestinal cells. The same 
mechanism takes place in the macrophage, where the release of iron recovered from 
senescent RBCs is inhibited. Hepcidin release from the liver is controlled by the 
erythropoietic need and body iron stores. In iron deficiency, hepcidin is downregulated, 
thus enhancing iron efflux by Fpn into the circulation. When serum iron levels are 
normal, Fpn is reduced following increased degradation caused by binding of hepcidin, 
thus inhibiting excess iron export into plasma (Nemeth and others 2004b).  
Interestingly, the hepcidin mechanism in inflammatory conditions has been a key 
component in understanding the physiology underlying inflammation and poor iron 
status.  
Chronic diseases, bacterial and viral infections and autoimmune diseases trigger 
immune responses by production of cytokines such as interleukin-1, interleukin-6, 
interleukin-10, TNF-α, interferon-γ. These cytokines cause different responses by iron 
regulatory proteins. For instance, hepcidin is up-regulated as a defense system in 
response to inflammation. Elevated hepcidin levels, through the down-regulation of 
Fpn, cause iron to be sequestered in enterocytes and macrophages, which inhibits iron 
release into the plasma. This results in reduced plasma iron levels, reduced 
erythropoiesis, and consequently anemia.  
Hepcidin is an acute phase reactant and its synthesis is triggered by IL-6 more 
than by IL-1α and TNF-α. Ferritin is synthesized in response to IL-1 α and TNF- α 
(Nemeth and others 2003; Nemeth and others 2004b). Recently, hepcidin expression 
was studied in chronically obese subjects. Adipocytes from these subjects showed 
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increased expression of hepcidin mRNA, which could lead to iron sequestration in 
enterocytes and macrophages (Bekri and others 2006).  In another study, serum hepcidin 
was negatively associated with iron absorption in healthy young women (Young and 
others 2009). This observation suggests that hepcidin is important in understanding iron 
status in obese and non-obese persons. 
 
Iron deficiency 
Iron deficiency (ID) corresponds to the depletion of a functional iron pool in 
different tissues to a sufficient degree so as to impair optimal function. Iron depletion in 
the body occurs in stages and can be measured by utilizing a battery of biomarkers of 
iron status. The total body iron content in a normal healthy adult is approximately 3.5- 
4.5 g/kg body weight (Andrews 1999).  Most of this iron is utilized and recycled by the 
circulating erythrocytes in the form of hemoglobin. The amount of iron taken up by 
immature RBCs for hemoglobin synthesis can account for up to 2.8 gm/kg body weight 
and 3.2 gm/kg body weight in women and men, respectively, and is delivered to these 
cells by the iron transport protein transferrin. About 0.6 gm of iron is utilized by 
myoglobin, transferrin and cytochromes. Any surplus body iron is stored in the cells in 
the form of ferritin and hemosiderin (Baynes and Stipanuk 2000).  Measurement of 
ferritin in plasma is a good indicator of body iron stores. When insufficient iron is 
available for hemoglobin synthesis, typical signs of iron deficiency anemia develop, 
including low blood hemoglobin and hematocrit and red blood cell microcytosis.   
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Etiology of iron deficiency and iron deficiency anemia 
Iron deficiency is the primary cause of anemia worldwide. Poor iron intake, 
inadequate bioavailable iron, blood loss due to menstruation and mucosal blood loss 
through intestinal cells are potential conditions that lead to iron depletion (Cook and 
Skikne 1989; Finch and Cook 1984).  Although there is no defined pathway for iron 
excretion, under normal condition about 1-2 mg of iron is typically lost from the body 
each day, primarily through occult blood loss into the intestine. This obligatory iron loss 
needs to be replaced through dietary iron absorption (Andrews 2000). 
A higher prevalence of iron deficiency anemia is commonly found in women 
than in men in industrialized as well as developing nations (Finch and Cook 1984). 
Menstrual loss and pregnancy are the principal reasons for iron deficiency in women of 
child-bearing age. Menstrual blood losses average up to 40-50 mL, thus accounting for a 
loss of nearly 24 mg of iron each month, which explains the increased iron requirements 
in this group of women (Hallberg and others 1966).  The RDA for women aged between 
19-50 years is 18 mg, which is more than twice as great as that of males (8mg).  
Optimal iron status during pregnancy is critical for maternal and fetal health. 
The expansion of plasma volume and fetal iron demand during pregnancy increases the 
RDA for iron in pregnancy up to 27 mg. (Baynes and Stipanuk 2000). Prenatal iron 
deficiency and iron deficiency anemia are associated with a doubling of the risk of 
preterm delivery and low infant birth weight (Scholl and Hediger 1994). Maintaining 
optimal iron status is essential even at the preconception stage. Iron deficiency anemia 
at this stage can result in abnormal pregnancy outcomes. A study in young Chinese 
women showed that poor iron status prior to pregnancy increased the risk of infant low 
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birth weight and growth restriction (Ronnenberg and others 2004). These data 
underscore the need to evaluate factors associated with the development of iron 
deficiency in pre-menopausal women.  
Stages of ID can be explained by successive depletion of iron from storage 
tissues to transport proteins, and finally manifesting as iron deficiency anemia (IDA).  
1. Iron depletion: Iron depletion starts from the storage site (ferritin in the bone 
marrow). At this stage, serum ferritin is the most sensitive indicator of body iron stores.  
2. Iron deficient erythropoiesis: Depletion of iron stores in the bone marrow results in 
reduced iron for erythroblasts, known as iron-deficient erythropoiesis. As a response to 
the reduction in iron stores, iron absorption and transport are enhanced by means of up 
regulation of proteins such as DMT-1, transferrin (Tf) and transferrin receptors (TfR). 
Therefore, iron depletion at this stage can be examined by a number of parameters such 
as mean cell volume (MCV), % transferrin saturation (TS), and free erythrocyte 
porphyrin (FEP) (Cook and Skikne 1989; Finch and Cook 1984). 
3. Iron deficiency anemia: The last stage of iron depletion is iron deficiency anemia 
(IDA). This can be assessed clinically by hemoglobin (Hb) content as well as serum 
transferrin receptor and ferritin (Cook, Skikne, Baynes 1993).   
 
Biomarkers of iron status 
Iron status may be assessed in various ways. The sensitivity and specificity of 
these parameters have been studied to identify the most accurate and reliable biomarkers 
of iron status. If iron depletion is diagnosed at an early stage, preventive measures of 
iron supplementation can be implemented to improve iron status.  
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Bone marrow examination 
Iron from the storage site is taken up by the erythroblasts present in bone 
marrow. Bone marrow examination includes histological assessment of iron stores. 
Although it is considered the most definitive measurement of iron status, it is not used 
for screening of iron deficiency in major populations because of its invasiveness. It is 
mainly used to assess iron status in hospitalized patients. (Cook and Skikne 1989) 
Hemoglobin 
Hemoglobin is iron bound to a protein in circulating erythrocytes. Hb is used for 
screening of anemia in large populations. However, it is not a reliable measure because 
there are different types of nutritional anemia which can result into false estimation of 
iron deficiency. The normal Hb levels can vary according to different populations as 
well as age, sex and hydration status. However, the cut-off level as per WHO standard is 
13g/dL for adult men, 12g/dL for non-pregnant women and 11g/dl for pregnant women 
(Cook and Skikne 1989). 
Free erythrocyte protoporphyrin (FEP) 
The heme molecule consists of protoporphyrin IX and iron. In the later stages of 
iron deficiency, free erythrocyte protoporphyrin levels increase as a manifestation of 
reduced heme synthesis. This is not the most sensitive indicator of iron deficiency, since 
it is a late stage of iron depletion leading to iron-deficient erythropoiesis. The cut-off 
value for FEP is 70µg/dL. Increased levels of FEP indicate iron deficiency anemia. 
(Cook and Skikne 1989) 
 
 
  15 
 
Mean cell volume (MCV) 
MCV is not sensitive to depletion of iron stores, but iron deficient erythropoiesis 
and iron deficiency anemia are associated with microcytosis (small cell volume), so 
MCV measurements are useful in determining the type of anemia. However, MCV can 
also decrease in infection or chronic disease, leading to a false assessment of iron 
deficiency anemia. Therefore, MCV alone is not considered a reliable measure of iron 
deficiency. The normal value for MCV is 80 fL.  (Cook and Skikne 1989) 
Transferrin saturation 
Transferrin saturation measures how much iron is bound to transferrin and is 
expressed in the form of “% saturation”. Transferrin saturation <16% reflects iron 
deficiency. Similar to other iron-related measures, such as Hb, MCV and FEP, 
transferrin saturation measurements are not sensitive to early stage depletion of iron 
body stores. Also, it can also be a false indicator of iron deficiency, since it can vary in 
case of clinical disorders. (Cook and Skikne 1989) 
Serum ferritin 
Iron is stored in the body in the form of ferritin. Using quantitative phlebotomy 
experiments in normal subjects, serum ferritin concentration was shown to reflect body 
iron stores in normal individuals, as well as in persons with iron deficiency or iron 
overload disorders; 1 ng/ml of serum ferritin reflects 8 mg of body iron stores (Walters, 
Miller, Worwood 1973). In case of dietary iron deficiency, iron stores are utilized to 
supply iron metabolic needs. Therefore, low serum ferritin concentrations reflect 
depleted body iron stores. In case of iron overload disorders, serum ferritin 
concentration is elevated above normal. Measurement of serum ferritin is the most 
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sensitive indicator of body iron stores in a normal healthy adult. Although cut-off values 
for serum ferritin have been defined by different population groups, the normal range of 
serum ferritin falls within 20-200 µg/L, with <12 µg/L indicative of depleted iron stores. 
(Baynes and Stipanuk 2000; Hallberg and others 1993)  
However, because ferritin protein is an acute-phase reactant that increases in 
response to inflammation or chronic disease, serum ferritin concentration can lead to a 
false indication of the extent of body iron stores in persons with concomitant infection 
or inflammation. (Punnonen, Irjala, Rajamaki 1997) 
Serum transferrin receptor 
A soluble truncated form of the transferrin receptor (TfR) can be detected in 
serum samples. The circulating transferrin receptor assay was first designed by Yutaka 
Kohgo et al.(1987). Iron deficiency gives rise to up regulation of cell surface expression 
of transferrin receptors that are reflected in an increase concentration of circulating 
soluble transferrin receptors (Kohgo and others 1987; Cook, Skikne, Baynes 1993). 
Similar to ferritin, the synthesis of TfR is also controlled by a post-transcriptional 
mechanism. When free iron is low in the cytoplasm, as in iron depletion, TfR synthesis 
is up regulated as a result of IRP binding with TfR mRNA.  
Because ferritin is an acute-phase reactant, its usability is compromised to some 
extent in cases of inflammation, liver disease and chronic disease. To distinguish iron 
deficiency anemia from the anemia of chronic disease (ACD), serum TfR measurements 
are a helpful indicator of iron deficiency, since its concentration is stable in 
inflammatory conditions (Cook, Skikne, Baynes 1993). However, when used alone, 
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serum TfR gives no information about body iron stores, and it is also affected by other 
conditions that influence the rate of erythropoiesis.  
Recently, some studies have used the ratio of soluble TfR to serum ferritin to 
distinguish iron deficiency anemia from anemia of inflammation. The index of sTfR- 
log ferritin has been found to be useful in assessment of body iron stores. (Punnonen, 
Irjala, Rajamaki 1997) 
 
Dietary factors affecting iron status 
Iron intake 
Heme and non-heme iron are two forms of iron available from animal and plant 
foods. Heme iron is derived from hemoglobin and myoglobin present in animal tissues, 
such as meat, seafood and poultry. Nonheme iron is also found in animal sources, 
including egg yolk and milk, as well as in plant sources, including fortified grains and 
cereals, leafy green vegetables, nuts, oilseeds and legumes (Baynes and Stipanuk 2000). 
A study by Hunt et al (1999) assessed non-heme iron absorption from a 
lactovegetarian diet compared to heme iron absorption. The bioavailability of heme iron 
(3.8%) was found to be 70% higher than that of nonheme iron (1.1%). (Hunt and 
Roughead 1999) This greater bioavailability is likely related to the structure of heme 
(Hb)3, which facilitates absorption and is unaffected by dietary inhibiting factors that 
influence absorption of nonheme iron. (Pizarro and others 2003) These studies indicate 
that heme iron intake enhances the bioavailability of iron. While this suggests that 
greater heme iron intake should improve iron status, recent studies have shown that 
dietary intake of heme and non-heme iron were not associated with iron status (Asakura 
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and others 2009; Pynaert and others 2007; Yanoff and others 2007). These observations 
suggest that, along with dietary iron intake, other nutritional and non-nutritional factors 
also influence iron absorption and iron status.  
Absorption of nonheme iron 
Nonheme iron absorption is a complex process that involves a number of other 
nutrients and dietary components that can be broadly classified as enhancers of or 
inhibitors of iron absorption.   
Enhancers of non-heme iron absorption 
 Ascorbic acid 
 The availability of the dietary iron can be enhanced by consumption of ascorbic 
acid. In previous studies, radioactive iron administered with vitamin C in single meal 
showed enhanced iron absorption as compared to the long term supplementation of 
vitamin C. One such study by Cook et al (2001) showed a positive correlation between 
log of iron absorption and log of vitamin C consumption. (Cook and Reddy 2001) 
Vitamin C is thought to enhance iron bioavailability by reducing insoluble ferric iron 
into ferrous form, which leads to increased absorption.  
Meat Factor 
The bioavailability of non-heme iron can be enhanced by addition of meat to the 
meal. This was tested in Latin-American basal meal, to which 75 g of ground beef meat 
was added, nearly tripling non-heme absorption from 0.17mg to 0.45 mg (Hallberg and 
Rossander 1984). Although the factors underlying this enhancing effect have not been 
identified yet, some studies have concluded that isolated protein extracts from muscle 
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proteins present in chicken and beef enhance non-heme iron absorption by 100% and 
180%, respectively (Hurrell and others 2006). 
Vitamin A  
Vitamin A is essential for vision, immunity, cellular differentiation and 
hematopoiesis. In addition, vitamin A supplementation improves iron status in many 
epidemiologic studies. A cross-sectional study in 1060 Thai children aged 1-8 years, 
which continued later with vitamin A intervention trial, indicated a positive association 
of retinol with iron status indices. In the intervention trial, vitamin A supplementation 
improved iron status significantly (Bloem and others 1989). Another study, conducted 
in 100 Venezuelan subjects, reported a significant increase in non-heme iron uptake 
when supplemented with varying concentrations of vitamin A and β-carotene. The 
meals were composed of rice, wheat and corn. Vitamin A and β-carotene improved the 
absorption of iron 0.8-, 1.4- and 2-fold for wheat, corn and rice, respectively.  The 
researchers suggested that vitamin A might have a binding effect on iron that makes it 
soluble and more bioavailable. Others have suggested that vitamin A could be 
responsible for mobilizing iron from ferritin stores to the circulation, thus enhancing 
erythropoiesis (Garcia-Casal and others 1998). 
Copper  
Copper deficiency and its relation to iron deficiency have been studied to a large 
extent. In-vivo studies have shown that copper deficiency causes a significant reduction 
in iron absorption to about 50% (Reeves and DeMars 2004). The possible underlying 
mechanism corresponds to altered function of a ferroxidase called hephaestin situated at 
the basolateral membrane of the intestinal cell. Hephaestin is responsible for oxidation 
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of Fe2+ to Fe3+, the latter is then transported into the blood stream. This ferroxidase is 
copper dependent, which justifies the mechanism of copper deficiency resulting in iron 
deficiency by restricting the passage of iron from enterocyte to the blood stream, thus 
leading to reduced serum iron. Deficiency can also adversely affect ceruloplasmin (Cp), 
which is a copper containing enzyme present in circulation. In other words, it is another 
form of ferroxidase responsible for iron transport (Reeves and DeMars 2004).  
 
Inhibitors of iron absorption 
Phytates 
Whole grains such as wheat, oats and rye that are not extensively processed have 
higher bran content. The bran or husk contains high amounts of phytates, which are also 
known as inositol phosphates. Cereal grains that are rich in phyates hinder iron 
absorption. A study by Mats Brune et al (1992) assessed the effect of phytates with 
different formulations of bread with combinations of different flours, and number of 
phosphates. The study showed that the higher the number of phosphates in inositol, the 
greater the inhibitory effect. Inositol phosphate is commonly seen in hexaphosphate or 
pentaphosphate form. Cooking methods such as fermentation and acidic media can 
reduce the number of phytates, thus attenuating its hindering effect to some extent. 
Fermentation breaks down phosphates to inorganic phosphates and reduces the number 
of phosphates, thus minimizing its effects. Also, the addition of lactic acid might 
decrease the phytate content in grains (Brune and others 1992). 
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Polyphenols 
Polyphenols are ring structures that contain more than one hydroxyl group. They 
are commonly found as tannic acid, gallic acid present in tea, coffee, red wine, spinach 
and spices such as cinnamon. These hydroxyl groups bind iron and make it unavailable 
for absorption (Zijp, Korver, Tijburg 2000).  The inhibitory effect of these polyphenols 
on iron absorption has been widely studied. One such study performed by Layrisse M et 
al examined iron absorption from controlled breakfast meals that included specific 
doses of tea and coffee. The results showed that a dose-dependent administration of tea 
and espresso coffee indicated a 50% decrease in iron absorption (Layrisse and others 
2000). This suggests that the consumption of tea and coffee is one of the important 
determinants of iron absorption.  
Calcium 
Calcium is critical for bone health. Although calcium supplementation may be 
beneficial for maintaining women’s bone health, it might also hinder iron absorption. 
Cook et al (1991) determined the effect of different calcium supplements on absorption 
of dietary labeled non-heme iron and supplemental iron in 61 subjects (28 women and 
33 men). When supplements containing both calcium carbonate and iron were taken 
without food, iron absorption was reduced by 15% (P= 0.10) as compared to 24% when 
taken with meal. (p=0.01). However, when the supplement was taken along with food 
with more bioavailable iron and low in calcium content, iron absorption was reduced up 
to 28% as against 55% reduced absorption in a meal with less bioavailable iron and high 
calcium content. (Cook, Dassenko, Whittaker 1991). Based on this study, it is evident 
that calcium has a potential inhibitory effect when consumed with meals. 
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Non-nutritional factors affecting iron status 
Blood loss 
Other than dietary deficiency, blood loss is one of the main factors that leads to 
iron depletion. Blood loss in terms of mucosal loss from the intestine, menstrual blood 
loss and blood donation can lead to depletion of iron stores and iron deficiency. A 
Danish study in women of childbearing age evaluated serum ferritin levels of 
menstruating as well as menopausal blood donors. The results indicated that serum 
ferritin levels for multiple time blood donors were significantly less than one-time 
donors, 19 µg/L versus 24 µg/L, respectively. Reduced serum ferritin levels were a 
result of frequency of blood donations as compared to number of donations. With the 
greatest frequency of four blood donations a year, serum ferritin levels were recorded as 
low as 16µg/L in menstruating women (Milman, Sondergaard, Sorensen 1985). Thus, 
frequency of blood donations can potentially modulate serum ferritin levels. 
The amount of menstrual blood loss is an important cause of iron loss in 
premenopausal women. The number of days in a menstrual period and the rate of blood 
loss determine iron stores. According to a study conducted by Milman N et al, serum 
ferritin concentration in premenopausal women was significantly lower than in post-
menopausal women, and 17% of the former had iron depleted stores, defined by serum 
ferritin <15µg/L. This was also supported by a more detailed study by a group in 
Finland (Fogelholm and others 1993) that observed that lower serum ferritin and Hb 
were associated with more frequent and longer menstrual periods.  
 
 
  23 
 
Use of contraceptives 
In a report by the CDC (2002), it was reported that in the age group of 15-44 
years, oral contraception was the preferred method (31%: 11.6 million) of contraception, 
followed by female sterilization (27%: 10.3 million), which was preferred by women 
over 35 years. The use of IUD is less than 3% in United States. (CDC 2002) 
The inter-relationship of use of Intra Uterine Device (IUD), oral contraceptives 
and iron status has been studied by various groups. Studies conducted in Swedish 
women showed that after the insertion of the IUD, increased menstrual blood loss was 
observed, but there was no considerable alteration of iron status (Larsson and others 
1993). However, a study in Finland observed a reduction in Hb and serum ferritin levels 
after insertion of copper IUD devices (Fogelholm and others 1993). Iron depletion is a 
result of many factors, so population differences may modulate the prevalence of this 
condition. For example, since IUD use is not very common in young population in 
United States, it is less likely to alter iron status in college–aged women in this country. 
On the other hand, oral contraception is likely to have a more important 
contribution to iron status due to its widespread use in this age group. The effect of oral 
contraceptives on iron status depends on the formulation of the pill. Oral contraceptive 
pills are primarily composed of synthetic estrogen and progestin hormones, which 
control the release of follicle stimulating hormone (FSH) and leutinizing hormone (LH). 
These hormones facilitate maturation and release of an ovum from the ovaries.  The 
synthesis of FSH and LH is inhibited by oral contraceptives. Thus, the principal 
mechanism of action of contraceptives is to prevent ovulation. Progestin also thickens 
the cervical mucus, thus preventing fertilization of the egg by sperm. This could result 
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in reduced endometrial proliferation and lighter menstrual flow (Burkman 2001; 
Casabellata and others 2007) and lower iron loss. A study by Frassinelli-Gunderson EP 
et al (1985) assessed the impact of oral contraceptives (OCs) on iron status parameters 
and found significant improvement in serum ferritin, TIBC, serum transferrin, MCV and 
serum iron (Frassinelli-Gunderson, Margen, Brown 1985). Milman N et al (1985) also 
reported that serum ferritin concentration was increased in women who used OCs 
(Milman, Sondergaard, Sorensen 1985). 
On the other hand, the use of low-dose oral contraceptives might not 
significantly improve iron status. Larsson et al (1992) studied the effect of low dose 
OCs in 20 young women, and found that serum ferritin status did not change 
significantly after six months.  The principal reason behind these contradictory findings 
might be the composition of OCs. Previously, OCs were composed of high-dose of 
estrogen and progestogen, as compared to the current low-dose products. The former 
OCs reduced the menstrual blood loss more than the low hormone formulas, thus 
resulting in improved iron status due to the higher administered hormone dose (Larsson 
and others 1992). 
 
Epidemiology of iron status and body composition 
Obesity has been linked to many chronic disorders such as diabetes, 
cardiovascular disease, and ischemic heart disease (Hubert and others 1983). Body 
composition measures, such as body mass index (BMI), percent body fat, and lean body 
mass, are useful measures of body composition. Several recent epidemiologic studies 
have described the association between iron status and measures of body composition 
  25 
 
and found a significant association between iron status and body fat in children and 
adults. 
In the Third National Health and Nutrition Examination Survey (NHANES III), 
the association between serum ferritin and adiposity was studied. Adiposity 
measurements included waist-to-hip ratio (WHR), BMI, waist-to-thigh ratio (WTR), 
and a combination of skinfold ratios. The study population was Mexican-American men 
(n=1416) 20-49 years of age. This population was selected considering the high 
prevalence of obesity observed in Mexican Americans and to eliminate potential 
confounding factors observed in females, such as menstruation, pregnancy, menopause 
and hormonal treatments. The study reported a positive correlation between serum 
ferritin with increased age, particularly when the 25-29 y age group was compared to the 
older age groups. WHR, BMI and other measured indices increased with increasing age. 
Serum ferritin was positively correlated with WHR, a moderately strong correlation 
(r=0.36) being found in age of 20-24 years. Other parameters such as  BMI (r=0.34), 
waist circumference (r=0.34) and sum of skinfolds (r=0.32) positively correlated with 
serum ferritin in all age groups, with the age group of 20-24 years being the highest. In a 
linear regression model, these associations remained statistically significant (P = 0.001) 
for the age subgroup of 20-29 years (Gillum 2001). 
One of the limitations of this study was that the accuracy of body fat mass 
estimations. Although anthropometrics have been used conventionally for obesity 
screening, DEXA (Dual Energy X-ray Absorptiometry) measurement is more accurate 
measure of body fat mass, fat distribution and lean body mass (Mazess and others 
1990). Also, because this study was limited to Mexican-Americans, its findings may not 
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be generalizable to other groups. This study also did not assess the relationship in young 
premenopausal women, where a variety of factors, such as oral contraceptive use, 
menstrual loss and pregnancy, other than adiposity might alter iron status.  
Two more studies that have observed this association studied an adult population 
whose mean age was approximately 50 years.  A New York City-based cohort included 
a racially diverse population (n=670; mean age 54+ 17years) comprised of males and 
females. DEXA, which is a gold standard for body composition measures, was used to 
assess body fat along with traditional methods, such as BMI and waist circumference. 
The overweight and obesity prevalence in the whole group was 60%, with similar BMIs 
for males and females (26.87+5.16). When studied based on gender and DEXA 
measures, females had a significantly higher percent body fat (37.8%) than males 
(24%). Similarly, fat mass was also greater in females (26.8 kg) than males (19.4 kg).  
The researchers (Chambers and others 2006) reported a negative correlation between 
serum iron and body fat measures such as BMI (r= -0.23, P<0.001), waist circumference 
and fat mass (r= -0.19, P < 0.05), although the correlation was significant only in the 
group of Hispanic women (Chambers and others 2006).  
As mentioned previously, serum ferritin is the most sensitive indicator of body 
iron stores (Cook and Skikne 1989). Therefore, it might have been more appropriate to 
use a combination of iron status indicators. Since the population was mostly adult (mean 
= 54 years), it might have included a large portion of postmenopausal women, which 
could have potentially altered iron status. Also, the results of this study were limited for 
Hispanic women, who have a greater prevalence of obesity and consequential iron 
deficiency. So, this may not represent what will be observed in all population groups. 
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Due to the limited information on the menstrual status, this effect could not be 
measured. This study also did not include other essential factors, such as dietary intake 
data, use of supplements, socio-economic status and activity level, that could influence 
iron status. Since these factors play vital roles in predicting iron status, and it is 
important to have complete data when assessing the iron status of populations. Thus 
selection of appropriate measurement parameters of fat mass as well as functional and 
storage iron is important to evaluate an interrelationship between the two factors. 
A recent study by Yanoff et al (2007) explored the possible reasons for the low 
serum iron levels (hypoferremia) observed in obesity. It was a comprehensive study that 
involved a wide range of iron status measurements, 7 day dietary intake records, an 
extensive questionnaire and various body fat indices including DEXA. This study 
involved a convenience sample of 234 obese and 172 non-obese subjects who were men 
and women of age 18-70 years from the Washington DC metro area. Excluded from the 
study were subjects with chronic and inflammatory diseases, which tend to alter iron 
levels. For body fat mass assessment, DEXA scans were performed following a 10-hour 
overnight fast. Iron status was assessed by measuring serum iron, serum ferritin, Hb, 
MCV, transferrin saturation and serum transferrin receptor. Although the study 
population aged ranged between 18-70 years, the mean age was in late 30s 
(approximately 38 years). Like other studies (Chambers and others 2006; Gillum 2001), 
this study also reported negative associations between serum iron and BMI and serum 
iron and fat mass (P= 0.0003) in univariate as well as in multivariate linear regression.. 
Transferrin saturation and MCV were also inversely associated with fat mass. (P <0.05) 
As expected, serum transferrin receptor and C-reactive protein (CRP; a marker of 
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inflammation) were positively correlated with the body fat measures. (P< 0.05) In 
multivariate analysis, serum ferritin was positively correlated with BMI and fat mass. 
(P<0.05) Dietary iron intake was not significantly associated with serum iron.  Elevated 
serum transferrin receptor, a biomarker of iron deficiency, was significantly more 
common in obese (26.9%) than in the non-obese group (15.7%). Based on 
socioeconomic levels, the proportion of whites in this study was higher in the non-
obese/healthy group as compared to the obese group, which had high proportion of 
African Americans. (Yanoff and others 2007)  
Although this study showed an inverse association between iron status and 
adiposity, it did not explore these relationships specifically in 18- to 30-year-olds. A 
significant relationship between body composition and iron status has also been 
observed in developing countries. An inverse association between body iron and BMI 
was seen in Moroccan and Indian children (p <0.0001). BMI Z-score was positively 
associated with serum ferritin (p =0.021), and transferrin receptor and zinc 
protoporphyrin (ZPP) (p<0.0001), and was negatively associated with estimates of body 
iron (ratio of serum ferritin/ transferrin receptor).  In the same study, an iron 
intervention trial (~4mg labeled iron fortification meal) in Thai women (19-50 years) 
reported association of decreased iron absorption and compromised iron status at a 
higher BMI (P = 0.030; P< 0.001, respectively). The change in body iron and serum 
ferritin in response to iron supplementation was negatively associated with a higher 
BMI in children (p<0.0001). (Zimmermann and others 2008) 
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Physiological evidence of serum hepcidin mechanism 
Although the biological mechanism behind iron deficiency and obesity is not 
clear, some mechanisms have been hypothesized. Stimuli by inflammatory adipokines 
such as IL-6 and TNF-α can up regulate hepcidin synthesis as well as sequester iron at 
storage sites. (Nemeth and others 2004a; Trayhurn and Wood 2004) To examine the 
physiological relationship underlying the association between adiposity and iron 
depletion, hepcidin expression was observed in hepatocytes and adipocytes of critically 
obese subjects. Hepcidin expression in adipose tissue was associated with IL-6 and CRP 
and 68% of the obese subjects were found to have low transferrin saturation and anemia 
was reported in 24% of obese population. (Bekri and others 2006) This study supports 
the idea that excess obesity is associated with hepcidin-mediated iron deficiency. 
To explore this association further, the effect of hepcidin on iron absorption was 
studied in young healthy women. Isotopic iron in the form of ferrous sulphate was 
administered to 18 young women, with and without a non-heme food source (sweet 
potato~ 1.4 mg Fe), followed by standardized meals. The experiment was repeated the 
next day and the iron absorption under the two conditions was assessed. Serum hepcidin 
levels were also analyzed and were found to be inversely associated with iron absorption 
both with and without food (p= 0.038; p= 0.0296 respectively). (Young and others 
2009) 
Other proposed mechanisms behind the inverse relationship between iron status 
and body fat include poor dietary intake of iron and increased requirement of iron 
attributed to larger blood volume. However, these two mechanisms have not been 
sufficiently tested yet. ((Menzie and others 2008; Yanoff and others 2007) 
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To summarize, there has been substantial evidence suggestive of an association 
of iron status with measures of body fat mass. However, very few studies have tried to 
determine this association in healthy young women. One such recent study by Karl et al 
(2009) attempted to examine the association of iron deficiency with BMI and body fat in 
young women who were military recruits. Among 207 women aged 18 to 41 years that 
were studied, 36.8% were iron deficient. However, iron deficiency (defined as: red cell 
distribution width > 15.0%, transferrin saturation < 16.0%, serum ferritin < 12.0 ng/mL) 
was not significantly different in groups of normal and overweight subjects. Moreover, 
BMI (25-30 kg/m2) and body fat (> 30% via skinfolds) were not significant predictors of 
iron status in this group of young women. Stratified analysis of body fat and BMI also 
did not indicate a significant risk of iron deficiency associated with adiposity. The 
findings of this study are contrary to what is expected based on the literature reviewed 
previously. The reason for this is unknown. However, the contradictory finding in this 
study might be suggestive of absence of such association in relatively healthy and young 
women. (Karl and others 2009) 
 
Epidemiology of physical activity, lean body mass and iron status 
Exercise can reduce fat mass. But certain levels of exercise have also been 
linked to a reduction in Hb and serum ferritin. In a study by Deruisseau et al, 40 college 
students were studied for iron status before and after a 12 week weight training exercise. 
Iron biomarkers such as Hb, serum ferritin, serum iron, TIBC, transferrin saturation and 
sTfR were examined before and after the training period. These parameters were 
examined for association with percent body fat and fat free mass (FFM) or lean body 
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mass. Calculation of percent body fat was based on body density formulas derived 
separately for black and white populations. After weight training, the study reported 
significant reduction in Hb from 13.7g/dl to 13.2 g/dl. Serum ferritin was significantly 
decreased only in males with normal iron status prior to training. These levels also fell 
significantly from 129.7 µg/L to 102.0 µg/L following training. For females, serum 
ferritin levels did not change post-training. Other biomarkers of iron also did not change 
significantly with training. Thus, weight training only had a negative effect on iron 
status in males. (Deruisseau and others 2004) 
McClung et al (2006) determined iron status in female military recruits (n=1216) 
with three differing levels of training—1) after initial entry to the Army (IET), 2) after 
basic combat training (AIT),  and 3) for the duration of permanent party assignment 
(PP) (McClung and others 2006). The level of iron deficiency and anemia was assessed 
using a three-variable criterion including serum ferritin, transferrin saturation and red 
cell distribution width (RDW). Abnormality in these variables represented iron 
deficiency, whereas Hb concentration below <12g/dl was predictive of iron deficiency 
anemia.  
Interestingly, a significant increase in iron deficiency was observed from 
baseline following basic combat training (BCT) (IET: 13.4% to AIT: 32.8%), which 
was reflected in a significant increase in IDA from 5.8% to 20.9%. In agreement with 
the earlier study, Hb concentration declined after basic combat training in the AIT 
group. Along with Hb, serum ferritin, transferrin saturation and hematocrit decreased 
significantly (p <0.001) and RDW increased post 2 weeks BCT.  (McClung and others 
2006) 
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Although the mechanism underlying negative iron status following physical 
training is unclear, one of the main reasons as stated by McClung and group was dietary 
iron insufficiency during the training period based on the previous field surveys. These 
surveys reported an inadequate dietary iron intake by female military personnel during 
the training period. The other proposed mechanisms include external loss of iron 
through sweat and urine, increased iron requirements due to expanded plasma volume 
and RBCs, which might lyse and lead to net iron losses (McClung and others 2006). 
Further research in this area is necessary to better understand the biological mechanism 
and relationship between iron status and strenuous physical activity (Deruisseau and 
others 2004; McClung and others 2006).   
 
Summary 
The prevalence of iron deficiency is highest (17.8%) among the women of child 
bearing age, in industrialized nations. (WHO 2002) In this age group, maintaining 
normal levels of iron is critical for the physiological functions of body. At the same 
time, there is evidence that excess adiposity can adversely affect iron deficiency in 
children and adults. Results can potentially vary depending on the study population, 
race, dietary habits, physical activity and other lifestyle factors. Therefore we proposed 
to study the association between iron status and body fat along with dietary, nutrient 
intake and lifestyle factors in a population of college-aged premenopausal young 
women. 
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Specific aims and hypotheses 
Specific aim 1 
We propose to assess the relationship between serum ferritin concentrations and iron 
deficiency, defined as serum ferritin < 12 µg/L, and body composition measures, 
including BMI and body fat percent, and the inflammatory biomarker, hs-CRP. 
Hypothesis 1 
a) Serum ferritin concentrations in women aged 18-30 yrs will be positively associated 
with BMI and percent body fat. 
b) CRP will be positively associated with body fat and serum ferritin. 
c) Body fat percent and serum hs-CRP will each be independently associated with 
reduced risk of iron deficiency. 
Specific aim 2 
We propose to identify dietary predictors of serum ferritin in young women and to 
assess the risk of suboptimal iron intake, defined as <18 mg/day (the RDA for women in 
this age group) by food groups. 
Hypothesis 2 
a) Serum ferritin levels will be positively associated with dietary intake of iron. 
b) Dietary factors known to inhibit or enhance dietary iron absorption will be either 
negatively or positively associated with ferritin levels. 
c) Meat, fish and poultry, followed by enriched cereals and vegetable consumption will 
be associated with reduced risk of suboptimal iron intake 
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Specific aim 3 
We propose to describe the impact of menstrual cycle characteristics and oral 
contraceptive use on serum ferritin levels and risk of iron deficiency in young women. 
Hypothesis 3 
Serum ferritin concentrations in young women will be positively associated with oral 
contraceptive use and associated with menstrual characteristics. OC use will be 
associated with reduced risk of iron deficiency. 
Specific aim 4 
We propose to determine the food group predictors of iron intake. 
Hypothesis 4 
a) Major predictors of iron intake will be meat, fish and poultry, followed by enriched  
 cereals and vegetables.  
b) Caffeine and alcoholic beverages will be inversely associated to total iron intake 
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CHAPTER 2 
STUDY METHODOLOGY 
Study design and population 
We obtained data from the University of Massachusetts Vitamin D Status Study, 
a cross-sectional study conducted at the University of Massachusetts, Amherst between 
2005 and 2008 to identify factors associated with vitamin D deficiency in young 
women. The eligibility criteria for the participants were: 1) 18-30 years old 2) currently 
having menstrual periods 3) absence of any chronic illness, and 4) no intake of 
medications known to affect vitamin D or calcium levels (eg, steroids, anticonvulsants, 
beta blockers or proton pump inhibitors). Data were available for a total of 185 women. 
All women provided written informed consent. The study protocol was approved by the 
Institutional Review Board of the University of Massachusetts Amherst.  
Anthropometric, dietary and health assessment 
The participants’ clinical visits were scheduled three to five days prior to their 
next estimated menstrual period. At this visit, participants were asked to complete a 
semi-quantitative food frequency questionnaire (Willett and others 1985) and a second 
questionnaire designed to obtain demographic data, information on general health, 
lifestyle habits, and menstrual characteristics.  Height, weight, and waist circumference 
were measured using a stadiometer, calibrated weighing scale, and non-stretch tape 
measure, respectively. Fasting blood samples were obtained by a trained phlebotomist at 
the University Health Center, where whole body Dual Energy X-ray Absorptiometry 
(DEXA) was also performed by a trained technician. Out of 185 eligible participants, 9 
participants did not have DEXA scan. Physical activity was calculated using metabolic 
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equivalents per week. (Ainsworth and others 1993) Menstrual characteristics, such as 
bleeding days, length of the menstrual cycle and menstrual pattern, as well as oral 
contraceptive use were obtained from the study questionnaire.  
Dietary assessment 
The food frequency questionnaire used for this study has been previously 
described in detail (Willet and others1985). The food frequency questionnaire is a 
modified version of the Harvard SFFQ containing 61 foods and has been previously 
validated. (Willett and others 1985)  Estimates of dietary intake of specific foods and 
dietary components, such as bran and individual nutrients, were calculated from 
specified portion sizes multiplied by the frequency of intake. Nutrient composition of 
the specified portion size was obtained from the USDA database. For the current study, 
the FFQ was used to assess food intake over the previous two months. In addition, a 
write-in question was added to the questionnaire to obtain additional information on the 
intake of vitamin-D fortified cereals and juices, which were not included in the original 
FFQ. Nutrients that were considered for the current analyses included total iron 
(mg/day), which included dietary and supplemental iron, vitamin A (RAE/day), vitamin 
C (mg/day), calcium (mg/day), copper (mg/day), magnesium (mg/day), zinc (mg/day), 
caffeine (mg/day), alcohol (g/day) and total dietary fiber (g/day). Food groups such as 
cereals, legumes, vegetables, fruits, dairy, eggs, meat, fish and poultry, coffee and tea, 
and alcoholic beverages were also included to assess their contribution to iron intake 
and their potential association with iron status, measured as serum ferritin 
concentration.) 
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Body composition measures 
Whole body DEXA scans were performed using the GE Lunar Prodigy Scanner 
(GE Lunar Corp., Madison, WI). The scans were performed with the participant lying in 
a supine position. The DEXA scanner was calibrated with a phantom as per the 
manufacturer’s instructions. The DEXA scans were used to calculate body fat and lean 
body mass as measures of body composition. Body mass index (BMI) was calculated as 
kg/m2 based on the participants’ recorded body weight and height.  
Laboratory analyses 
Fasting venous blood samples obtained from the participants were kept on ice 
for one to two hours before being centrifuged to obtain serum, which was aliquoted and 
frozen at -80° C until subsequent biomarker assessment.  Serum ferritin concentrations 
were determined as a measure of iron status using a commercially available enzyme 
immunoassay (EIA) kit (RAMCO Laboratories, TX). In brief, duplicate 10-µL serum 
samples and purified alkaline phosphatase-conjugated antihuman ferritin antibody were 
pipetted into 96-well microplates coated with solid phase antihuman ferritin antibody.  
After 2 hrs of incubation with shaking at 180 rpm at room temperature, the plates were 
washed three times with deionized water. Substrate solution was added and allowed to 
stand for 30 minutes. Potassium ferricyanide was then added to develop a color. The 
absorbance was read at 490 nm and a background correction wavelength of 630 nm 
using a 96-well plate reader (Dynex Revelation , Dynex Technologies, Chantilly, VA).  
Absorbance values were entered into the Spectro Ferritin MT- calculation program 
provided by RAMCO laboratories for calculation of ferritin concentrations.  
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High sensitivity C- reactive protein (hs-CRP) was assessed by a latex-enhanced 
turbidimetric immunoassay kit (Equal Diagnostics, Exton, PA) using an automated 
analyzer and a high sensitivity calibration curve. The high sensitivity method allows 
detection of CRP in the range of 0.05 mg/L to 80.0 mg/L. CRP levels exceeding the 
higher level were diluted and retested using a multiplication by dilution factor.  
 
Statistical Analysis 
Statistical analyses were conducted using SPSS Windows version 16.0 (SPSS 
Inc. Chicago, IL).  Descriptive statistics (mean, SD) were used to characterize the 
population in terms of continuous variables, such as age, BMI (kg/m2), percent body fat, 
percent lean mass, waist circumference (inches), physical activity (METs/week), and 
serum concentrations of hs-CRP (mg/L) and ferritin (µg/L). Descriptive methods were 
also used to characterize dietary intakes of food groups  (as cereals, lentils, vegetables, 
fruits, dairy, eggs, meat, fish and poultry, coffee and tea and alcoholic beverages) and 
nutrients [total iron (mg/day), dietary iron, supplemental iron, vitamin A (RAE/day), 
vitamin C (mg/day), calcium (mg/day), copper (mg/day), magnesium (mg/day), zinc 
(mg/day), caffeine (mg/day), alcohol (g/day) and total dietary fiber (g/day)].  
Categorical variables such as race, oral contraceptive use, smoking status, 
menstrual characteristics are presented as N and percentages. Iron deficiency was 
defined as serum ferritin <12 µg/L. For the categorical analysis of covariates, the 
variables such as percent body fat (< 24, 24- 32, >32), BMI (<25, >25) and CRP (<3, >3 
mg/L) were classified using standard cut off values. The nutrient intake covariates were 
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dichotomized using age- and gender-appropriate RDA cut-off levels for respective 
nutrients.  
The Kurtosis test revealed that neither outcome variable (iron intake or serum 
ferritin) was normally distributed, so we improved the normality of the distributions by 
transforming serum ferritin to its square root, and by obtaining the natural log of iron 
intake. These transformed values were used in tests (linear regression) that assume a 
normal distribution of the outcome variable.  
Significant differences in median ferritin concentrations by covariate categories 
were identified using non-parametric tests, including the Wilcoxon Rank Sum Test (two 
medians) and the Kruskal Wallis Test (three or more medians).  Analysis of 
dichotomized serum ferritin by covariates was performed using Wilcoxon Rank Sum 
Test for continuous covariates and chi-square analysis for categorical covariates. 
Correlation analysis was performed using Pearson’s correlation coefficient, with square 
root transformed serum ferritin as a dependent variable.  
 Separate univariable linear regression analyses were carried out to identify 
possible predictors of total iron intake (natural log) and serum ferritin (square root). All 
covariates that had a p value of <0.25 in univariable models were included in the initial 
multivariable model. Body composition measures, such as BMI and body fat percent, 
were strongly correlated with one another (r= 0.73; p= 0.00), so they were not included 
in the same models to avoid issues regarding collinearity between the independent 
variables.  
After this first step of multivariable analysis, we excluded the covariates with a p 
value >0.15. The final multivariable linear regression model for the predictors of iron 
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intake included all of the food groups; supplemental iron and total energy intake were 
also included in the final model. The final multivariable linear regression model for 
serum ferritin predictors included age, hs-CRP, body fat percent, iron intake, oral 
contraceptive use, bleeding days and total energy intake. The data are presented as R2, 
beta coefficient, 95% confidence intervals and p value.  
Univariable logistic regression was performed with dichotomized serum ferritin 
(< 12 µg/L) and iron intake (< 18 mg/day) to assess the risk of iron depletion and low 
dietary iron intake, respectively. The final multivariable logistic regression model for 
iron depletion included age, hs-CRP, iron intake, body fat percent, bleeding days and 
oral contraceptive use. The final multivariable logistic regression model for low iron 
intake included all the food groups (cereals, lentils, vegetables, fruits, dairy, eggs, meat, 
fish and poultry, coffee and tea and alcoholic beverages), and supplemental iron. The 
results of logistic regression were presented as odds ratio, 95% confidence intervals and 
p value. For all analyses, statistical significance was set at p<0.05.  
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CHAPTER 3 
RESULTS 
Our study included 185 18- to 30-year old women from Amherst, Massachusetts. 
The demographic characteristics of the population as well as dietary and other factors 
thought to influence ferritin status are presented in Table 1.  The population was mostly 
young and predominantly white, with a few Asians and African Americans. Most 
women had a BMI within the normal range, although percent body fat was greater than 
32 in nearly half of the women. 
Serum ferritin (SF) concentration ranged from 1.4 to 114.3 µg/L. Overall, 28% of 
women had serum ferritin concentrations <12 µg/L. The mean concentration of high 
sensitivity C-reactive protein (hs-CRP mg/L) was 3.0 (5.9), with 70% of the population 
below the cut off level (< 3mg/L) associated with increased cardiovascular disease risk 
(Mainous and others 2004). Percent body fat and hs-CRP were significantly correlated. 
(r=0.3; p=0.00) 
 Oral contraceptives (OCs) were currently being used by nearly 40% of women. 
Only about 6% of women reported that their menstrual pattern was irregular. Nearly 
two-thirds of women reported a cycle length of 26 to31 days, and 70% reported four to 
five bleeding days per cycle. Physical activity in reference to energy expenditure at rest 
was measured as metabolic equivalents tasks per week classified by intensity of activity 
(METs). The mean score in this population was 58.6 (54.9).  Although mean intakes of 
nutrients were above the RDA for women in this age group, the range of intakes 
indicates that many women were not achieving RDA levels (Table 2).  
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Because serum ferritin concentration was not normally distributed, we used 
nonparametric methods to compare serum ferritin medians across the categories of 
covariates (Table 3). Median serum ferritin was significantly higher in women over 21 
years of age (the median) than in younger women. Median ferritin was also significantly 
higher among women with hs-CRP levels greater than 3 mg/L than in those with lower 
hs-CRP concentrations. Although serum ferritin was significantly lower among current 
OC users (24.8 ± 22.8) than in nonusers (28.3 ± 20.5; p =0.04), no other significant 
differences in median ferritin were observed across categories of menstrual 
characteristics. Median ferritin levels did not differ across categories of nutrients (≥ 
RDA vs. < RDA; data not shown).   
We conducted univariable linear regression analyses to evaluate the associations 
between potential covariates and (square root) serum ferritin (Table 4). Age and hs-CRP 
were significantly and positively associated with serum ferritin. None of the body 
composition parameters (BMI, percent body fat) was associated with serum ferritin, but 
the number of bleeding days was strongly inversely associated with serum ferritin.  
Although consumption of nutrients such as vitamin A and copper were strongly 
associated with serum ferritin (p ≤ 0.05), total iron intake and iron intake from food 
only were not (p > 0.05) 
 In multivariable linear regression analyses, age, hs-CRP, OC use and number of 
bleeding days remained significantly associated with serum ferritin (Table 5). Dietary 
nutrients that were significantly associated with serum ferritin in univariable analyses 
were no longer significant in the multivariable models. Consistent with the univariable 
  43 
 
analysis, body fat percent was not associated with serum ferritin while controlling for 
other factors (Table 6).  
We also used linear regression analyses to identify the dietary predictors of iron 
intake (logarithmically transformed). In univariable analyses (Table 7), cereals, legumes, 
vegetables and fruits were significantly associated (p <0.01) with total iron intake, 
although meat intake was not. Supplemental iron intake was also a strong, significant 
predictor of total iron intake (R2 =0.42; p = 0.00). In a multivariable model that was not 
adjusted for meat intake, (Table 8), cereals, legumes, vegetables, fruits, eggs, 
supplemental iron (p<0.01) and dairy (p<0.05) remained significant predictors of iron 
intake, and the coefficient estimates remained similar after removing nuts, coffee and 
tea from the model (Table 9). However, when meat intake was forced into this model 
(Table 10), it became a strong predictor (p <0.01) of total iron intake, along with 
cereals, legumes, vegetables, fruits, and supplemental iron. 
We used univariable logistic regression analyses to identify factors associated with 
risk of iron deficiency, which we defined as serum ferritin <12 µg/L (Table 11). Each 
one-year increase in age was associated with a 15% decrease in the risk of iron 
deficiency Compared to current OC use, the risk of iron deficiency was 53% lower in 
non OC users. No other covariates were significantly associated with iron deficiency in 
univariable analyses.   
Categories of percent body fat, hs-CRP categories, and other factors in the 
univariable model that were significant at the p < 0.25 level were included in a 
multivariable logistic regression model (Table 12). The significant predictors in the 
univariable models remained significant in the multivariable analysis. While the odds 
  44 
 
ratio for most covariates were virtually unchanged, the protective effect associated with 
non-use of contraceptives was more pronounced when controlling for other factors 
(OR= 0.29; 95% CI 0.12-0.67). In addition, compared to those who reported three or 
fewer menstrual  bleeding days, the risk of iron deficiency was more than six-times 
greater among women in the highest category of bleeding days (6-7 days; OR = 6.2; 
95% CI 1.3-29.3).  
We also used univariable logistic regression to identify dietary factors associated 
with risk of suboptimal iron intake, which we defined as < 18 mg per day, the RDA for 
women in this age group (Table 13).  Dietary intake of cereals, vegetables, fruits, 
legumes and supplemental iron were all protective against suboptimal iron intake, 
although intake of meat was not significantly associated with risk of suboptimal intake.  
The multivariable logistic model of suboptimal iron intake (Table 14) included all 
covariates with a p value < 0.25 in the univariable models. Increased intake of cereals, 
legumes and supplemental iron remained protective against inadequate iron intake in the 
multivariable model. While fruit and vegetable intake tended to be protective, their 
effect was no longer statistically significant in the multivariable model. Meat intake was 
also significantly protective against inadequate iron intake after controlling for other 
dietary factors and supplemental iron intake.  Alcohol intake was associated with a near 
doubling of the risk of inadequate iron intake, but this effect did not reach statistical 
significance.  
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CHAPTER 4 
DISCUSSION 
Iron status is of special concern in women of child-bearing age because it 
influences not only the woman’s health, but also that of her infant if she becomes 
pregnant. Our study focused on young, apparently healthy premenopausal women. We 
found no association between serum ferritin concentration and measures of body 
composition, including BMI and percent body fat.  
Our results are in contrast to those of several earlier studies, which reported 
associations between adiposity and various markers of iron status, with the direction of 
the association depending on the iron biomarker (e.g., inverse for serum iron, positive 
for serum ferritin) (Chambers and others 2006; Iwasaki and others 2005; Yanoff and 
others 2007) However, the study populations in previous reports generally differed from 
ours in terms of age, sex and race, and these factors can influence not only iron status, 
but also body composition (Chambers and others 2006; Yanoff and others 2007; 
Iwasaki and others 2005) For instance, in the study by Chambers et al (2006) and 
Iwasaki et al (2005), the subjects included postmenopausal women, and the mean age of 
the study participants was over 50 years (Chambers,E.C. 2006; Iwasaki,T. 2005) 
Although the study by Yanoff et al (2007)  included subjects within our range of 18 to 
30 years, the mean age of their cohort (38 years) was substantially higher than the 
average age of women in our study (21.5 years).  We also observed a positive 
association between serum ferritin concentration and age. This association has been 
reported previously by Gillum et al.(2001), using data from NHANES. They found that 
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increased age was positively associated with serum ferritin, especially in the third 
decade of life.(Gillum 2001)  Although the mechanism for an age-associated change in 
ferritin level is not yet clear, it is possible that the differences in mean age among 
studies could potentially influence the relationship between serum ferritin and adiposity, 
particularly since adiposity has also been reported to increase with age. (Gillum 2001)  
In addition to differences in age, the mean BMI and percent body fat in previous 
studies were also much greater than in our study. For instance, in the study by Yanoff et 
al. (2007), the mean BMI of the “nonobese” group was 25.6 kg/m2, compared to 22.8 
kg/m2in our study. The fact that Yanoff et al. (2007) reported an association between 
obesity and serum ferritin concentration, suggests that the degree of adiposity might 
play a major role in predicting body iron status. In other words, an association might be 
observed in women with a higher percent body fat but not in those in the normal range 
of adiposity.  
Race may also influence the relationship between ferritin and body composition. 
For instance, although the NHANES study (Gillum et al, 2001) reported a significant 
relationship between serum ferritin and body fat measurements, the analysis was limited 
to Mexican American males, and it is possible that the relationship is different in a 
group of women who are predominantly Caucasian.  
The results of our study are consistent with the very recent findings of Karl et al 
(2009), in which high body fat percent (> 30% via skinfolds) and BMI (25-30 kg/m2) 
were not associated with iron deficiency (defined as two or more of the following blood 
indicators: red cell distribution width > 15.0%, transferrin saturation < 16.0%, serum 
ferritin < 12.0 ng/mL) in premenopausal women, ranging in age from 18 to 41 years. 
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These authors speculate that a “critical level of fat mass” may be needed to induce the 
inflammatory condition that leads to altered iron status. (Karl and others 2009) 
We found a positive association between hs-CRP and serum ferritin, which has 
been well- documented in previous studies. (Mainous and others 2004; Yanoff and 
others 2007) CRP is a hepatic protein that is released in response to inflammation. 
Although ferritin serves primarily as a storage form of iron, it is also a positive acute- 
phase reactant that, like CRP, rises in response to inflammatory signals, including 
adipokines released by adipocytes. (Jehn, Clark, Guallar 2004; Weiss and Goodnough 
2005; Yanoff and others 2007) In our study, we found that hs-CRP was positively 
associated percent body fat and BMI (r=0.28 and 0.19, respectively).  
Based on the study by Yanoff et al (2007), one can postulate that higher body fat 
may result increased iron stores in the form of serum ferritin. This can be explained by 
the physiological association of the inflammatory response to fat accretion. In our study, 
hs-CRP was significantly correlated with serum ferritin as well as body fat measures. 
This indicates that the inflammatory cytokines are triggered in response to increased 
body fat. Consequently, as a defense mechanism, hepcidin is released. Hepcidin is an 
iron regulatory protein that inhibits the release of iron from macrophages and 
enterocytes, thus causing increased serum ferritin and decreased circulatory iron. 
(Nemeth and others 2004c) The inflammatory response can also be explained by 
increase in ferritin synthesis as an acute phase response, resulting into decreased 
absorption of iron by the small intestine. (Weiss and Goodnough 2005) The hepcidin 
mechanism was elucidated in a study where, hepcidin expression was observed in 
hepatocyes as well as adipocytes of severely obese subjects. Hepcidin expression was 
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positively correlated with inflammatory biomarkers such as CRP (Bekri and others 
2006; Yanoff and others 2007). This can possibly explain the contradictory findings in 
our study.  
We found that mean serum ferritin was significantly higher in non-users of OCs 
than in current users. In addition, we found that the risk of iron deficiency was also 53% 
lower in nonusers than in those currently using OCs. The influence of OC use on iron 
status has been studied extensively, with conflicting findings. Earlier studies 
(Frassinelli-Gunderson, Margen, Brown 1985; Milman, Sondergaard, Sorensen 1985) 
reported an improvement in iron status after the use of OCs for six months. However, 
other studies have shown that the use of low-dose or third generation OCs does not alter 
iron status significantly (Casabellata and others 2007; Larsson and others 1992), 
possibly due to the fact that the low hormonal dose in current OCs reduces menstrual 
blood loss to a lesser extent than did earlier contraceptive pills. It is also possible that 
women in our study were prescribed OCs due to iron-deficiency anemia,  which could 
explain the lower concentration of ferritin observed in OC users if the women had not 
yet had time to become iron replete. Future studies will need to assess other factors 
related to OC use, such as the reason for their initiation and the duration of use.  
Among the menstrual characteristics, the number of reported bleeding days was 
significantly associated with ferritin concentration. This observation is supported by 
many studies, which clearly demonstrate the inverse association between number of 
bleeding days as well as the intensity of menstrual loss and iron status indicators. 
(Fogelholm and others 1993; Milman, Sondergaard, Sorensen 1985) These results are 
also consistent with a recent study in Japanese young women, which found that 
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increased bleeding days and extreme menstrual losses were strong predictors of iron 
deficiency. (Asakura and others 2009)  
With respect to nutrient intake, we found that total iron intake (dietary iron plus 
supplemental iron) was not a significant predictor of ferritin concentration in either 
univariable or multivariable linear regression analyses. In addition, iron intake was not a 
significant risk factor for iron deficiency (ferritin < 12 µg/L). This finding is similar to 
that reported by Pynaert et al (2007), who also concluded that iron intake did not 
influence iron status parameters in young adult women.  Although intake of other 
nutrients, including vitamin A and copper, was significantly associated with serum 
ferritin in univariable regression models, these nutrients were no longer significant in 
multivariable models. Our findings are in agreement with those of Asakura et al (2009), 
who studied1019 young Japanese women (18-25 years). Their study of 16 nutrients 
concluded that none of the dietary components was significantly associated with iron 
deficiency (serum ferritin <12 µg/L). .  
We further explored the contribution of various food groups to dietary iron intake. 
In univariable models (Table 7), nonheme iron sources such as cereals, vegetables, 
lentils and fruit were positively associated with total iron intake, although heme iron 
sources (“meat,” which included meat, fish and poultry) were not. However, when 
supplemental iron was included in multivariable models, meat intake also became 
significantly associated with total iron intake.   
The contribution of cereals to total iron intake can be explained by the fact that 
many cereal products are either iron-fortified or made with iron-enriched flour, and 
these types of foods are often a large proportion of the total diet.  The positive 
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association between cereal intake and total dietary iron was also reported in Belgian 
study by Pynaert et al (2007). They found that cereals and vegetables (31% and 10%, 
respectively) were significant predictors of total iron intake and that meat intake (12%) 
was also a significant contributor to iron intake.  
 
Strengths and limitations 
One important strength of the current study is that our population of young women 
was healthy and relatively homogeneous in terms of race and education level, which 
reduced between-person variation and improved our ability to detect associations among 
our exposure and outcome measures. Moreover, the relationship between iron status and 
body fat has rarely been studied in young and predominantly non-obese women, and our 
study group was relatively lean. Another important strength was our use of DEXA 
measurements to assess adiposity in addition to conventional methods of body fat 
assessment, such as BMI and waist circumference. Because  DEXA is considered a 
more accurate and reliable method of determining body composition, our use of this 
technology strengthened our assessment of adiposity. 
Iron status in young women depends on several important contributing factors, 
including dietary intake of iron and other nutrients, menstrual characteristics, oral 
contraceptive use and physical activity. Our ability to measure these factors in the 
current study made our study more comprehensive than previous studies and 
strengthened our ability to reduce random error.   
One limitation of our study was that it relied solely on serum ferritin as the only 
biomarker of iron status. Because serum ferritin increases in response to inflammation, 
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normal or elevated levels may be falsely interpreted as iron sufficiency if the subject is 
in an inflammatory state. Although inflammation is generally associated with infection 
or tissue damage, increased adiposity is also a pro-inflammatory state, and we did 
observe a positive association between hs-CRP levels and measures of adiposity (r=0.3; 
p=0.00). Although we can be confident that women with serum ferritin <12 µg/L were 
in fact iron deficient (28% of our study group), we cannot be certain that women with 
ferritin concentrations >12 µg/L were necessarily iron replete, particularly if their hs-
CRP levels were elevated. However, we found that only 13 of the women in our study 
had hs-CRP levels > 8 mg/L, indicative of a substantial acute-phase response.  Of those, 
just three had borderline ferritin levels (12.5 to 31 µg/L) that would suggest that the 
women may have been misclassified as iron replete.  Other measures of iron status, such 
as serum iron or serum transferrin receptor, may have provided a broader understanding 
of the relationship between iron status, inflammation and body fat.  
Although also a strength, another potential limitation of our study was the fact that 
our cohort consisted of young, predominantly Caucasian women who were generally 
within the normal range of BMI.  Although measures of percent body fat suggested that 
45% of women were somewhat overfat (>32%), they did not appear to be extremely so, 
and it is possible that the level of adiposity that we observed was not sufficient to 
promote an inflammatory response. Although hs-CRP was associated with adiposity, we 
found no difference in mean serum ferritin concentrations across percent body fat 
categories.  Additional studies are needed to confirm these findings in older and more 
ethnically diverse populations that have a wider distribution of BMI and percent body 
fat measurements. 
  52 
 
Conclusion 
This study demonstrated that body composition was not associated with ferritin 
status or the risk of iron deficiency in a group of young premenopausal women. 
Although inflammation plays a key role in predicting iron status, as evidenced by the 
association between hs-CRP and ferritin concentration or risk of iron deficiency, and hs-
CRP was associated with percent body fat, we did not find a significant association 
between adiposity and ferritin status. We also found that, despite the greater efficiency 
of heme iron absorption, dietary components—including meat intake--did not 
significantly predict serum ferritin levels. Additional studies are needed to further 
explore the dietary and lifestyle factors that influence iron status in young women. 
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TABLES 
Table 1: Characteristics of study population 
 (N= 185) 
(Continues on the next page) 
 N % Range Mean    (SD) 
Age 
 
Height (cm) 
 
Weight (kg) 
 
BMI (kg/m2 ) 
< 25 
≥ 25 
 
Body Fat % 
<32 
>32 
 
Waist Circumference (in) 
 
Physical Activity (METs) * 
 
Race 
White 
Black African American 
Asian 
Other 
 
Serum Ferritin (mcg/L) 
<12 mcg/L 
>12 mcg/L 
 
Hs-CRP (mg/L) 
< 3 
> 3 
 
Current Oral Contraceptive Use 
Yes 
No 
 
 
 
 
185 
 
185 
 
185 
 
185 
142 
  43 
 
176 
  92 
  84 
 
185 
 
185 
 
185 
158 
    4 
  13 
  10 
 
181 
  51 
134 
 
179 
130 
  49 
 
185 
  73 
112  
 
 
 
 
 
 
 
 
 
 
 
76.8 
23.2 
 
 
49.7 
45.4 
 
 
 
 
 
 
85.4 
  2.2 
  7.0 
  5.4 
 
 
27.6 
72.4 
 
 
70.3 
26.5 
 
 
39.5 
60.5 
 
   
   
 
18.0 – 31.0 
 
149.9-182.9 
 
40.6-87.5 
 
16.8- 33.0 
 
 
 
14.5- 50.1 
 
 
 
24.0- 45.0 
 
0-374.2 
 
 
 
 
 
 
 
1.4- 114.3 
 
 
 
0.1- 42.8 
 
 
 
 
 
 
 
 
 
 
21.5 (3.2) 
 
166.4   (6.0) 
 
63.4     (9.8) 
 
22.8 (3.1) 
 
 
 
31.9 (7.9) 
 
 
 
30.9 (3.4) 
 
58.6   (54.9) 
 
 
 
 
 
 
 
26.9 (21.4) 
 
 
 
3.0 (5.9) 
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Current Smoking Status 
Yes 
No 
 
 
Menstrual Characteristics 
Menstrual Pattern 
Extremely regular 
Very regular 
Regular 
Usually irregular 
Always irregular 
 
Length of period (days) 
<21  
21-25  
26-31  
32-39  
40-50  
>51  
 
Bleeding days 
< 3  
4-5  
6-7  
 
185 
    9 
176 
 
 
185 
  70 
  53 
  52 
    7 
    3 
 
 
185 
    2 
  39 
116 
  21 
    1 
    6 
 
185 
  28 
129 
  28 
 
 
4.9 
95.1 
 
 
 
37.8 
28.6 
28.1 
  3.8 
  1.6 
 
   
 
  1.1 
21.1 
62.7 
11.4 
  0.5 
  3.2 
 
 
15.1 
69.7 
15.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Metabolic equivalents per week 
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Table 2: Distribution of food group and nutrient intakes in study population 
 (N= 185) 
 
Variable Range  Mean (SD) 
 
Food group intake 
(servings/day) 
Cereal 
Legumes 
Vegetables 
Fruits 
Dairy 
Eggs 
Meat* 
Coffee and tea 
Alcoholic beverages 
 
Nutrient Intakes (per day) 
Iron (mg) 
Total  
Food only 
Supplemental 
Vitamin C (mg) 
Carotenoids (RAE) 
Retinol (RAE) 
Vitamin A (RAE) 
Copper (mg) 
Calcium (mg) 
Magnesium (mg) 
Zinc (mg) 
Caffeine (mg) 
Bran (g) 
Fiber (g)** 
Alcohol (g) 
 
 
 
 
0.4- 14.1 
0.0- 4.5 
0.2- 22.8 
0.0- 10.1 
0.0- 10.9 
0.0- 6.0 
0.0- 5.6 
0.0- 9.0 
0.0- 5.0 
 
 
 
4 – 101 
4 – 73 
0.0- 87 
16- 1626 
75-15074 
12 -4521 
357 -16886 
0.3- 6 
129 – 3553 
79- 1057 
3 – 72 
0.0- 880 
0.1- 35 
6 – 120 
0.0- 70 
 
 
 
 
3.4 (2.1) 
0.3 (5.4) 
5.0 (3.4) 
2.6 (1.8) 
2.6 (1.8) 
0.4 (0.6) 
1.2 (1.0) 
1.1 (1.3) 
0.4 (0.6) 
 
 
 
25 (16) 
19 (10) 
6          (13) 
208 (180) 
4410    (2978) 
802 (653) 
5172    (3004) 
2 (0.9) 
1151 (506) 
419      (177) 
18 (10) 
95 (109) 
6 (5) 
30 (18) 
6 (8) 
 
*  Includes meat, fish and poultry 
**
 Total fiber intake per day 
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Table 3: Distribution of median serum ferritin (µg/L) by covariate categories 
(Cotinues on the next page) 
Covariates N % Median (range) P value* 
Age 
≤ 21 yrs 
> 21 yrs 
 
Race 
White 
Black African American 
Asian 
Other 
 
BMI (kg/m2) 
< 25 
≥ 25 
 
Body Fat % 
≤ 24 
24-32 
> 32 
 
Hs-CRP (mg/L) 
≤ 3 
> 3 
 
Current Oral Contraceptive Use 
Yes 
No 
 
Current Smoking Status 
Yes 
No 
 
Menstrual Characteristics 
Menstrual Pattern 
Extremely regular 
Very regular 
Regular 
Usually irregular 
Always irregular 
 
 
 
185 
111 
  74 
 
 
158 
    4 
  13 
  10 
 
 
142 
  43 
 
 
  40 
  61 
  84 
 
 
130 
  49 
 
    
72 
112 
 
     
    9 
176 
 
 
 
  70 
  53 
  52 
    7 
    3 
 
   
    
 
59.7 
40.3 
 
 
85.4 
  2.2 
  7.0 
  5.4 
 
 
76.8 
23.2 
 
 
21.6 
33.0 
45.4 
 
 
70.3 
26.5 
 
 
39.5 
60.5 
 
 
  4.9 
95.1 
 
 
 
37.8 
28.6 
28.1 
  3.8 
  1.6 
 
   
 
 
19.4  (1.4-97.2) 
26.6  (2.6-114.6) 
 
 
21.5  (1.4-97.2) 
26.0  (4.9-51.5) 
36.8  (5.8-114.3) 
22.1  (8.0-87.5) 
 
 
21.1  (1.4-97.2) 
24.4  (2.6-114.3) 
 
 
20.1  (3.2-114.0) 
23.2  (1.9-80.2) 
22.3  (1.4-114.3) 
 
 
20.3  (1.4-114.0) 
24.1  (3.4-114.3) 
 
 
17.3  (2.4-114.0) 
24.7  (1.4-114.3) 
 
 
33.6 (7.6-69.9) 
21.1 (1.4-114.3) 
 
 
 
18.8 (3.8-114.0) 
27.5 (1.4-114.3) 
18.1 (1.9-56.8) 
26.8 (8.8-30.3) 
23.9 (8.0-40.7) 
 
 
 
 
0.01 
 
 
 
0.16 
 
 
 
 
 
0.43 
 
 
 
0.90 
 
 
 
 
0.04 
 
 
 
0.04 
 
 
 
0.11 
 
 
 
 
0.15 
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Length of period (days) 
<21  
21-25  
26-31  
32-39  
40-50  
>51  
 
Bleeding days 
< 3  
4-5  
6-7  
 
 
    
    2 
  39 
116 
  21 
    1 
    6 
 
 
  28 
129 
  28 
 
 
 
 
 
1.1 
21.1 
62.7 
11.4 
  0.5 
  3.2 
 
 
15.1 
69.7 
15.1 
 
 
46.6  (44.2-48.9) 
25.3 (2.4-94.5) 
20.6 (1.9-114.3) 
17.3 (1.4-86.9) 
40.7 (40.7-40.7) 
23.9 (7.8-70.1) 
 
 
25.3 (2.6-97.2) 
22.0 (1.9-114.3) 
19.1 (1.4-60.5) 
 
 
 
0.19 
 
 
 
 
 
 
 
0.11 
 
 
 
 
 
* Wilcoxon Rank Sum Test and Kruskal Wallis Test, as appropriate, for the comparison of two or three 
plus groups, respectively 
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Table 4: Univariable regression analysis of serum ferritin (sq root) by covariates 
 
Predictor Beta R2 P value* 
 
Age (yrs) 
 
Race 
 
BMI (kg/m2 ) 
 
Waist Circumference (inches) 
 
Body Fat % 
 
Hs-CRP 
 
Physical Activity (METs)** 
 
Current Oral Contraceptive use 
 
Current smoking status 
 
Menstrual Characteristics 
Menstrual Pattern 
Length of period 
Bleeding days 
 
Nutrient Intake (per day) 
Iron (mg) 
Total 
Food Only 
Vitamin C (mg) 
Vitamin A (mcg RAE) 
Copper (mg) 
Calcium (mg) 
Magnesium (mg) 
Zinc (mg) 
Caffeine (mg) 
Fiber (g) 
Alcohol (g) 
 
 
 
0.15  
 
0.22 
 
0.03 
 
0.01 
 
0.002 
 
0.09 
 
-0.001 
 
0.45 
 
-0.79 
 
 
-0.15 
-0.08 
-0.59 
 
 
 
0.01 
0.009 
0.001 
0.00 
0.30 
0.00 
0.001 
0.02 
0.00 
0.01 
0.00 
 
 
 
0.06 
 
0.02 
 
0.00 
 
0.00 
 
0.00 
 
0.08 
 
0.00 
 
0.01 
 
0.01 
 
 
0.01 
0.00 
0.03 
 
 
 
0.02 
0.00 
0.02 
0.03 
0.02 
0.00 
0.01 
0.01 
0.00 
0.01 
0.00 
 
 
 
0.001 
 
0.06 
 
0.53 
 
0.77 
 
0.89 
 
0.00 
 
0.57 
 
0.12 
 
0.23 
 
 
0.29 
0.65 
0.02 
 
 
 
0.10 
0.52 
0.10 
0.03 
0.05 
0.98 
0.13 
0.17 
0.91 
0.17 
0.97 
 
 
*Covariates with p-value <0.25 were included in a multivariable regression model 
** Metabolic Equivalents per week 
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Table 5: Multivariable regression analysis of serum ferritin by covariates * 
 
Predictor§ Beta P value§ 
Model : 
R2 = 0.186 
 
Age (yrs) 
 
hs- CRP (mg/L) 
 
Oral contraceptive use 
 
Bleeding days 
 
 
 
 
 
0.13 
 
0.09 
 
0.76 
 
-0.55 
 
 
 
 
 
0.002 
 
0.00 
 
0.01 
 
0.03 
 
 
 
*Model not adjusted for body fat percent 
§   Covariates that had p-value of < 0.25 (race, iron intake, vitamin C, vitamin A, copper, magnesium, zinc, 
fiber) were not significant in the intermediate multivariable model, thus removed in the final model 
 
 
 
Table 6: Multivariable linear regression analysis of serum ferritin by covariates ** 
 
Predictor Beta P value 
Model : 
R2 = 0.188 
 
Age (yrs) 
 
hs- CRP (mg/L) 
 
Body fat % 
 
Oral contraceptive use 
 
Bleeding days 
 
 
 
 
 
0.13 
 
0.10 
 
-0.01 
 
0.78 
 
-0.55 
 
 
 
 
 
0.004 
 
0.00 
 
0.49 
 
0.01 
 
0.03 
 
 
 
** Model adjusted for body fat percent 
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Table 7: Univariable regression analysis of iron intake* by food groups 
 
Predictor Beta R2 P value** 
Food group 
(Servings/day) 
 
Cereals 
 
Legumes 
 
Meat § 
 
Eggs 
 
Dairy 
 
Vegetables 
 
Fruits 
 
Nuts 
 
Coffee & tea 
 
Alcohol 
 
Supplemental iron 
 
 
 
0.05 
 
0.15 
 
0.02 
 
0.03 
 
0.02 
 
0.03 
 
0.04 
 
0.07 
 
0.02 
 
-0.02 
 
0.01 
 
 
 
0.19 
 
0.10 
 
0.01 
 
0.01 
 
0.02 
 
0.15 
 
0.07 
 
0.02 
 
0.01 
 
0.00 
 
0.42 
 
 
 
0.00 
 
0.00 
 
0.31 
 
0.23 
 
0.06 
 
0.00 
 
0.00 
 
0.07 
 
0.15 
 
0.49 
 
0.00 
 
* Log transformed iron intake 
** Covariates with p value < 0.25 were included in a multivariable model 
§ Includes meat, fish and poltry 
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Table 8: Multivariable regression analysis of iron intake* by food groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Log transformed iron intake 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Predictor Beta P value 
Model : R2 = 0.77 
Food groups (servings/day) 
 
Cereal 
 
Legumes 
 
Eggs 
 
Dairy 
 
Vegetables 
 
Fruits 
 
Nuts 
 
Coffee and tea 
 
Supplemental iron 
 
 
 
 
 
 
0.05 
 
0.05 
 
0.04 
 
0.01 
 
0.01 
 
0.02 
 
0.02 
 
0.01 
 
0.01 
 
 
 
 
 
 
0.00 
 
0.01 
 
0.01 
 
0.03 
 
0.00 
 
0.01 
 
0.38 
 
0.52 
 
0.00 
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Table 9: Multivariable regression analysis of iron intake by food groups* 
 
Predictor** Beta P value 
Model : R2 = 0.79 
Food groups (servings/day) 
 
Cereal 
 
Legumes 
 
Dairy 
 
Vegetables 
 
Fruits 
 
Eggs 
 
Supplemental iron 
 
 
 
 
 
0.05 
 
0.06 
 
0.01 
 
0.01 
 
0.02 
 
0.04 
 
0.01 
 
 
 
 
 
0.00 
 
0.01 
 
0.03 
 
0.00 
 
0.01 
 
0.01 
 
0.00 
 
 
* Unadjusted for meat intake per day 
** Excludes nuts, meat, coffee and tea, alcoholic beverages 
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Table 10: Multivariable regression analysis of iron intake by food groups* 
 
Predictor Beta P value 
Model : R2 = 0.77 
Food groups (servings/day) 
Cereal 
 
Legumes 
 
Dairy 
 
Vegetables 
 
Fruits 
 
Eggs 
 
Meat 
 
Supplemental iron 
 
 
 
 
0.05 
 
0.06 
 
0.01 
 
0.01 
 
0.02 
 
0.02 
 
0.04 
 
0.01 
 
 
 
0.00 
 
0.002 
 
0.06 
 
0.00 
 
0.003 
 
0.09 
 
0.001 
 
0.00 
 
* Adjusted for meat intake per day 
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Table 11: Unadjusted univariable odds ratio for iron deficiency* by covariates 
 
 Odds Ratio 95% CI P value 
Age (yrs) 
 
hs- CRP (mg/L) 
 
Body fat % 
 
Iron intake (mg/day) 
 
Physical activity (METs/wk) 
 
Oral contraceptive use 
Yes 
No 
 
Bleeding Days 
< 3  
4-5  
6-7 
 
Categorized variables: 
   hs- CRP 
     < 3 mg/L 
     > 3 mg/L 
 
   Body Fat % 
     <32 
     >32 
 
 
0.85 
 
0.96 
 
0.99 
 
0.99 
 
1.00 
 
 
1.00 
0.47 
 
 
1.00 
2.41 
3.33 
 
 
 
1.00 
0.64 
 
 
1.00 
0.71 
0.75- 0.98 
 
0.90- 1.04 
 
0.95- 1.04 
 
0.96- 1.01 
 
0.99- 1.01 
 
 
ref 
0.24- 0.90 
 
 
ref 
0.78- 7.43 
0.90- 12.36 
 
 
 
Ref 
0.29- 1.42 
 
 
Ref 
0.37- 1.40 
0.02 
 
0.33 
 
0.81 
 
0.21 
 
0.87 
 
 
 
0.02 
 
 
 
0.16 
0.07 
 
 
 
 
0.28 
 
 
 
0.33 
 
*Iron deficiency defined as serum ferritin < 12mcg/L 
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Table 12: Adjusted odds ratio for iron deficiency* by covariates 
 
 Odds Ratio 95% CI P value 
Age (yrs) 
 
hs- CRP (mg/L) 
< 3 mg/L 
     > 3 mg/L 
 
Body fat % 
<32 
     >32 
 
Iron intake (mg/day) 
 
Oral contraceptive use 
Yes 
No 
 
Bleeding Days 
< 3  
4-5  
6-7 
 
 
0.84 
 
 
1.00 
0.50 
 
 
1.00 
0.85 
 
0.99 
 
 
1.00 
0.29 
 
 
1.00 
2.54 
6.24 
0.72- 0.99 
 
 
ref 
0.2- 1.4 
 
 
ref 
0.4- 1.4 
 
0.96- 1.02 
 
 
Ref 
0.12- 0.67 
 
 
Ref 
0.7 - 9.3 
1.3 – 29.3 
 
0.04 
 
 
 
0.17 
 
 
 
0.69 
 
0.37 
 
 
 
0.004 
 
 
 
0.16 
0.02 
 
*Iron deficiency defined as serum ferritin < 12mcg/L 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  66 
 
Table 13: Unadjusted univariable odds ratio for suboptimal iron intake* by food 
groups 
 
 Odds ratio 95% CI P value 
Cereal 
    
Vegetables 
 
Fruits 
 
Legumes 
 
Dairy 
 
Eggs 
 
Meat  
 
Coffee and Tea 
 
Alcohol 
 
Supplemental iron 
 
 
0.54 
 
0.78 
 
0.76 
 
0.07 
 
0.91 
 
0.78 
 
0.83 
 
0.88 
 
1.45 
 
0.75 
 
 
0.42- 69 
 
0.68- 0.89 
 
0.62- 0.93 
 
0.02- 0.25 
 
0.76- 1.08 
 
0.47- 1.29 
 
0.61- 1.13 
 
0.70- 1.11 
 
0.87- 2.40 
 
0.64- 0.87 
0.00 
 
0.00 
 
0.007 
 
0.00 
 
0.27 
 
0.33 
 
0.24 
 
0.27 
 
0.15 
 
0.00 
 
* Suboptimal iron intake based on RDA cut off value of <18mg per day 
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Table 14: Adjusted odds ratio for suboptimal iron intake* by food groups§ 
 
 Odds Ratio 95% CI P value 
Cereal 
    
Vegetables 
 
Fruits 
 
Legumes 
 
Meat 
 
Supplemental iron 
 
Alcoholic beverages 
 
0.32 
 
0.81 
 
0.72 
 
0.07 
 
0.25 
 
0.57 
 
1.83 
0.2 - 0.5 
 
0.6 - 1.02 
 
0.5 - 1.02 
 
0.01- 0.5 
 
0.1- 0.5 
 
0.4 - 0.8 
 
0.9 – 3.9 
0.00 
 
0.08 
 
0.07 
 
0.006 
 
0.00 
 
0.00 
 
0.12 
 
* Suboptimal iron intake based on RDA cut off value of <18mg per day 
§
 Excluded variables: eggs, dairy, coffee and tea 
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